Scott Hutton Sells 29,708 Shares of Biodesix, Inc. (NASDAQ:BDSX) Stock

Biodesix, Inc. (NASDAQ:BDSX – Get Free Report) CEO Scott Hutton sold 29,708 shares of the firm’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $1.66, for a total transaction of $49,315.28. Following the transaction, the chief executive officer now directly owns 465,011 shares in the company, […]

Related Keywords

United States ,Scott Hutton ,William Blair ,Tower Research Capital ,Biodesix Inc ,Nasdaq ,Oracle Investment Management Inc ,Wells Fargo Company ,Legato Capital Management ,Canaccord Genuity Group ,Biodesix Company Profile ,Get Free Report ,Trading Down ,Investment Management ,Research Capital ,Capital Management ,State Street Corp ,Street Corp ,Nodify Lung Nodule Risk Assessment ,Biodesix Daily ,Biodesix ,Nasdaq Bdsx ,Bdsx ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,